• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

First Reported Case of metallo-beta-lactamase 2009 Carbapenem-Positive Gene in Escherichia coli from Companion Animals in the United States

Gert van der Hoek

In Memoriam - Editor, Senior Moderator
First Reported Case of New Delhi Metallo (NDM) Carbapenem-Positive Gene in Escherichia coli from Companion Animals in the United States

Tuesday, Sep 11, 2012

Abstract: Background: Carbapenems are used to treat serious infectious caused by gram-negative bacteria. Resistance to carbapenems is mediated by the production of Class A, D, and B metallo-β-lactamase enzymes (MBLs). This study characterized the prevalence of genes producing New Delhi metallo (NDM)-β-lactamases in Escherichia coli isolates from companion animals in the United States.

Methods: Antimicrobial susceptibility was determined for canine and feline clinical E. coli isolates collected from veterinary laboratories throughout the US between 2008 and 2009. Isolates (n=100) which exhibited reduced susceptibility to ceftazidine or cefotaxime (MIC≥16 µg/ml) or meropenem (MIC≥1 µg/ml) were analyzed. The presence of genes encoding for carbapenemases (blaKPC, blaNDM, blaAIM, blaGIM, blaSIM, blaDIM, blaIMP, blaVIM, blaSPM and blaOXA-48) were investigated by PCR. PCR amplicons were sequenced and BLASTed to confirm the gene identity. Plasmid analysis by S1 nuclease-PFGE, Southern hybridization, and conjugation experiments were performed on all NDM-positive isolates.

Results: PCR and sequencing identified the presence of blaNDM gene in six E. coli isolates. Other carbapenemases encoding genes were not detected. The meropenem MIC values for NDM producing isolates ranged from 0.5 to 16 µg/ml. NDM-positive isolates (n=6) were also resistant to doxycycline (n=2), enrofloxacin (n=2), trimethoprim/sulfamethoxazole (n=1) or gentamicin (n=2). An isolate successfully conjugated with a recipient strain, E. coli J53 AZr, with ampicillin selection, and the resulting transconjugant that exhibited resistance to meropenem (MIC 4 µg/ml). PCR and DNA sequencing confirmed the presence of blaNDM gene in the transconjugant. The transconjugant also exhibited resistance to cefazolin, cefotaxime, cefpodoxime, ceftiofur, ceftriaxone, cephalothin, and cefoxitin. NDM encoding gene (blaNDM) was detected by Southern hybridization in plasmid DNA (30 kb to 150 kb) from the NDM-positive isolates.

Conclusions: This work highlights the first reported case of NDM carbapenemases-positive gene in E. coli from companion animals in the United States.

OASIS

Thanks to Maryn McKenna

More details and usefull comment in Maryn McKenna's blog.
 
Back
Top Bottom